nodes	percent_of_prediction	percent_of_DWPC	metapath
Dicyclomine—CHRM3—muscle of abdomen—obesity	0.00798	0.489	CbGeAlD
Dicyclomine—Lethargy—Bupropion—obesity	0.00176	0.00296	CcSEcCtD
Dicyclomine—Delirium—Topiramate—obesity	0.00176	0.00296	CcSEcCtD
Dicyclomine—Speech disorder—Topiramate—obesity	0.00176	0.00296	CcSEcCtD
Dicyclomine—Nausea—Benzphetamine—obesity	0.00175	0.00295	CcSEcCtD
Dicyclomine—Sensory loss—Topiramate—obesity	0.00174	0.00294	CcSEcCtD
Dicyclomine—Urticaria—Phentermine—obesity	0.00174	0.00294	CcSEcCtD
Dicyclomine—Muscular weakness—Sibutramine—obesity	0.00174	0.00294	CcSEcCtD
Dicyclomine—Abdominal pain—Phentermine—obesity	0.00174	0.00293	CcSEcCtD
Dicyclomine—Insomnia—Diethylpropion—obesity	0.00173	0.00291	CcSEcCtD
Dicyclomine—Diplopia—Bupropion—obesity	0.00172	0.00291	CcSEcCtD
Dicyclomine—Abdominal distension—Sibutramine—obesity	0.00172	0.0029	CcSEcCtD
Dicyclomine—Dyspnoea—Diethylpropion—obesity	0.0017	0.00287	CcSEcCtD
Dicyclomine—Somnolence—Diethylpropion—obesity	0.0017	0.00286	CcSEcCtD
Dicyclomine—Affect lability—Bupropion—obesity	0.0017	0.00286	CcSEcCtD
Dicyclomine—Hypersensitivity—Phenylpropanolamine—obesity	0.00169	0.00285	CcSEcCtD
Dicyclomine—Headache—Phendimetrazine—obesity	0.00168	0.00284	CcSEcCtD
Dicyclomine—Dyspepsia—Diethylpropion—obesity	0.00168	0.00284	CcSEcCtD
Dicyclomine—Face oedema—Bupropion—obesity	0.00166	0.0028	CcSEcCtD
Dicyclomine—Gastrointestinal disorder—Diethylpropion—obesity	0.00165	0.00278	CcSEcCtD
Dicyclomine—Urinary retention—Bupropion—obesity	0.00164	0.00276	CcSEcCtD
Dicyclomine—Constipation—Diethylpropion—obesity	0.00163	0.00276	CcSEcCtD
Dicyclomine—Mood swings—Bupropion—obesity	0.00163	0.00275	CcSEcCtD
Dicyclomine—Somnolence—Cimetidine—obesity	0.00162	0.00273	CcSEcCtD
Dicyclomine—Dyskinesia—Topiramate—obesity	0.00161	0.00271	CcSEcCtD
Dicyclomine—Nausea—Phendimetrazine—obesity	0.0016	0.00269	CcSEcCtD
Dicyclomine—Asthenia—Phentermine—obesity	0.00158	0.00266	CcSEcCtD
Dicyclomine—Feeling abnormal—Diethylpropion—obesity	0.00157	0.00265	CcSEcCtD
Dicyclomine—Erectile dysfunction—Sibutramine—obesity	0.00157	0.00265	CcSEcCtD
Dicyclomine—Fatigue—Cimetidine—obesity	0.00157	0.00264	CcSEcCtD
Dicyclomine—Breast disorder—Bupropion—obesity	0.00156	0.00263	CcSEcCtD
Dicyclomine—Constipation—Cimetidine—obesity	0.00155	0.00262	CcSEcCtD
Dicyclomine—Muscular weakness—Bupropion—obesity	0.00152	0.00256	CcSEcCtD
Dicyclomine—Urticaria—Diethylpropion—obesity	0.00152	0.00256	CcSEcCtD
Dicyclomine—Dizziness—Phenylpropanolamine—obesity	0.00152	0.00256	CcSEcCtD
Dicyclomine—Abdominal distension—Bupropion—obesity	0.0015	0.00253	CcSEcCtD
Dicyclomine—Feeling abnormal—Cimetidine—obesity	0.0015	0.00253	CcSEcCtD
Dicyclomine—Vomiting—Phenylpropanolamine—obesity	0.00146	0.00246	CcSEcCtD
Dicyclomine—Dizziness—Phentermine—obesity	0.00145	0.00245	CcSEcCtD
Dicyclomine—Rash—Phenylpropanolamine—obesity	0.00145	0.00244	CcSEcCtD
Dicyclomine—Dermatitis—Phenylpropanolamine—obesity	0.00145	0.00244	CcSEcCtD
Dicyclomine—Vomiting—Phentermine—obesity	0.0014	0.00235	CcSEcCtD
Dicyclomine—Rash—Phentermine—obesity	0.00138	0.00234	CcSEcCtD
Dicyclomine—Dermatitis—Phentermine—obesity	0.00138	0.00233	CcSEcCtD
Dicyclomine—Headache—Phentermine—obesity	0.00138	0.00232	CcSEcCtD
Dicyclomine—Erectile dysfunction—Bupropion—obesity	0.00137	0.00231	CcSEcCtD
Dicyclomine—Nausea—Phenylpropanolamine—obesity	0.00136	0.0023	CcSEcCtD
Dicyclomine—Hypoaesthesia—Sibutramine—obesity	0.00136	0.00229	CcSEcCtD
Dicyclomine—Hypersensitivity—Cimetidine—obesity	0.00134	0.00226	CcSEcCtD
Dicyclomine—Nausea—Phentermine—obesity	0.0013	0.0022	CcSEcCtD
Dicyclomine—Asthenia—Cimetidine—obesity	0.0013	0.0022	CcSEcCtD
Dicyclomine—Eye disorder—Sibutramine—obesity	0.00128	0.00215	CcSEcCtD
Dicyclomine—Immune system disorder—Orlistat—obesity	0.00128	0.00215	CcSEcCtD
Dicyclomine—Mediastinal disorder—Orlistat—obesity	0.00127	0.00215	CcSEcCtD
Dicyclomine—Dizziness—Diethylpropion—obesity	0.00126	0.00213	CcSEcCtD
Dicyclomine—Mental disorder—Orlistat—obesity	0.00124	0.00209	CcSEcCtD
Dicyclomine—Immune system disorder—Sibutramine—obesity	0.00123	0.00208	CcSEcCtD
Dicyclomine—Disorientation—Topiramate—obesity	0.00123	0.00207	CcSEcCtD
Dicyclomine—Vomiting—Diethylpropion—obesity	0.00121	0.00205	CcSEcCtD
Dicyclomine—Nasal congestion—Topiramate—obesity	0.0012	0.00203	CcSEcCtD
Dicyclomine—Rash—Diethylpropion—obesity	0.0012	0.00203	CcSEcCtD
Dicyclomine—Dermatitis—Diethylpropion—obesity	0.0012	0.00203	CcSEcCtD
Dicyclomine—Dizziness—Cimetidine—obesity	0.0012	0.00203	CcSEcCtD
Dicyclomine—Headache—Diethylpropion—obesity	0.0012	0.00202	CcSEcCtD
Dicyclomine—Hypoaesthesia—Bupropion—obesity	0.00119	0.002	CcSEcCtD
Dicyclomine—Hallucination—Bupropion—obesity	0.00119	0.002	CcSEcCtD
Dicyclomine—Amnesia—Topiramate—obesity	0.00117	0.00197	CcSEcCtD
Dicyclomine—Tension—Sibutramine—obesity	0.00117	0.00197	CcSEcCtD
Dicyclomine—Vision blurred—Orlistat—obesity	0.00116	0.00195	CcSEcCtD
Dicyclomine—Nervousness—Sibutramine—obesity	0.00116	0.00195	CcSEcCtD
Dicyclomine—Vomiting—Cimetidine—obesity	0.00116	0.00195	CcSEcCtD
Dicyclomine—Rash—Cimetidine—obesity	0.00115	0.00193	CcSEcCtD
Dicyclomine—Dermatitis—Cimetidine—obesity	0.00114	0.00193	CcSEcCtD
Dicyclomine—Ill-defined disorder—Orlistat—obesity	0.00114	0.00192	CcSEcCtD
Dicyclomine—Headache—Cimetidine—obesity	0.00114	0.00192	CcSEcCtD
Dicyclomine—Nausea—Diethylpropion—obesity	0.00113	0.00191	CcSEcCtD
Dicyclomine—Angioedema—Orlistat—obesity	0.00112	0.00189	CcSEcCtD
Dicyclomine—Vision blurred—Sibutramine—obesity	0.00112	0.00189	CcSEcCtD
Dicyclomine—Lethargy—Topiramate—obesity	0.00112	0.00189	CcSEcCtD
Dicyclomine—Eye disorder—Bupropion—obesity	0.00111	0.00188	CcSEcCtD
Dicyclomine—Malaise—Orlistat—obesity	0.00111	0.00187	CcSEcCtD
Dicyclomine—Cardiac disorder—Bupropion—obesity	0.00111	0.00187	CcSEcCtD
Dicyclomine—Ill-defined disorder—Sibutramine—obesity	0.0011	0.00186	CcSEcCtD
Dicyclomine—Diplopia—Topiramate—obesity	0.0011	0.00185	CcSEcCtD
Dicyclomine—Agitation—Sibutramine—obesity	0.00109	0.00184	CcSEcCtD
Dicyclomine—Angioedema—Sibutramine—obesity	0.00109	0.00183	CcSEcCtD
Dicyclomine—Palpitations—Orlistat—obesity	0.00109	0.00183	CcSEcCtD
Dicyclomine—Affect lability—Topiramate—obesity	0.00108	0.00182	CcSEcCtD
Dicyclomine—Nausea—Cimetidine—obesity	0.00108	0.00182	CcSEcCtD
Dicyclomine—Immune system disorder—Bupropion—obesity	0.00108	0.00182	CcSEcCtD
Dicyclomine—Mediastinal disorder—Bupropion—obesity	0.00107	0.00181	CcSEcCtD
Dicyclomine—Malaise—Sibutramine—obesity	0.00107	0.00181	CcSEcCtD
Dicyclomine—CHRM2—cardiovascular system—obesity	0.00107	0.0655	CbGeAlD
Dicyclomine—Syncope—Sibutramine—obesity	0.00107	0.0018	CcSEcCtD
Dicyclomine—Face oedema—Topiramate—obesity	0.00106	0.00179	CcSEcCtD
Dicyclomine—Palpitations—Sibutramine—obesity	0.00105	0.00177	CcSEcCtD
Dicyclomine—Loss of consciousness—Sibutramine—obesity	0.00105	0.00176	CcSEcCtD
Dicyclomine—Mental disorder—Bupropion—obesity	0.00104	0.00176	CcSEcCtD
Dicyclomine—Urinary retention—Topiramate—obesity	0.00104	0.00176	CcSEcCtD
Dicyclomine—Mood swings—Topiramate—obesity	0.00104	0.00175	CcSEcCtD
Dicyclomine—Discomfort—Orlistat—obesity	0.00103	0.00174	CcSEcCtD
Dicyclomine—Hypertension—Sibutramine—obesity	0.00103	0.00173	CcSEcCtD
Dicyclomine—Dry mouth—Orlistat—obesity	0.00102	0.00173	CcSEcCtD
Dicyclomine—Tension—Bupropion—obesity	0.00102	0.00172	CcSEcCtD
Dicyclomine—Nervousness—Bupropion—obesity	0.00101	0.0017	CcSEcCtD
Dicyclomine—Anaphylactic shock—Orlistat—obesity	0.001	0.00169	CcSEcCtD
Dicyclomine—Oedema—Orlistat—obesity	0.001	0.00169	CcSEcCtD
Dicyclomine—Discomfort—Sibutramine—obesity	0.001	0.00169	CcSEcCtD
Dicyclomine—Breast disorder—Topiramate—obesity	0.000992	0.00167	CcSEcCtD
Dicyclomine—Dry mouth—Sibutramine—obesity	0.000991	0.00167	CcSEcCtD
Dicyclomine—Nervous system disorder—Orlistat—obesity	0.000984	0.00166	CcSEcCtD
Dicyclomine—Confusional state—Sibutramine—obesity	0.000979	0.00165	CcSEcCtD
Dicyclomine—Vision blurred—Bupropion—obesity	0.000977	0.00165	CcSEcCtD
Dicyclomine—CHRM1—cardiovascular system—obesity	0.000973	0.0596	CbGeAlD
Dicyclomine—Oedema—Sibutramine—obesity	0.000971	0.00164	CcSEcCtD
Dicyclomine—Anaphylactic shock—Sibutramine—obesity	0.000971	0.00164	CcSEcCtD
Dicyclomine—Muscular weakness—Topiramate—obesity	0.000968	0.00163	CcSEcCtD
Dicyclomine—Ill-defined disorder—Bupropion—obesity	0.000962	0.00162	CcSEcCtD
Dicyclomine—Shock—Sibutramine—obesity	0.000955	0.00161	CcSEcCtD
Dicyclomine—Abdominal distension—Topiramate—obesity	0.000955	0.00161	CcSEcCtD
Dicyclomine—Agitation—Bupropion—obesity	0.000953	0.00161	CcSEcCtD
Dicyclomine—Angioedema—Bupropion—obesity	0.000948	0.0016	CcSEcCtD
Dicyclomine—Tachycardia—Sibutramine—obesity	0.000948	0.0016	CcSEcCtD
Dicyclomine—Malaise—Bupropion—obesity	0.000935	0.00158	CcSEcCtD
Dicyclomine—Syncope—Bupropion—obesity	0.00093	0.00157	CcSEcCtD
Dicyclomine—Anorexia—Sibutramine—obesity	0.000926	0.00156	CcSEcCtD
Dicyclomine—Palpitations—Bupropion—obesity	0.000917	0.00155	CcSEcCtD
Dicyclomine—Loss of consciousness—Bupropion—obesity	0.000912	0.00154	CcSEcCtD
Dicyclomine—Insomnia—Orlistat—obesity	0.000907	0.00153	CcSEcCtD
Dicyclomine—Paraesthesia—Orlistat—obesity	0.000901	0.00152	CcSEcCtD
Dicyclomine—Hypertension—Bupropion—obesity	0.000895	0.00151	CcSEcCtD
Dicyclomine—Dyspepsia—Orlistat—obesity	0.000883	0.00149	CcSEcCtD
Dicyclomine—Insomnia—Sibutramine—obesity	0.000878	0.00148	CcSEcCtD
Dicyclomine—Erectile dysfunction—Topiramate—obesity	0.000873	0.00147	CcSEcCtD
Dicyclomine—Discomfort—Bupropion—obesity	0.000872	0.00147	CcSEcCtD
Dicyclomine—Decreased appetite—Orlistat—obesity	0.000872	0.00147	CcSEcCtD
Dicyclomine—Paraesthesia—Sibutramine—obesity	0.000872	0.00147	CcSEcCtD
Dicyclomine—Gastrointestinal disorder—Orlistat—obesity	0.000866	0.00146	CcSEcCtD
Dicyclomine—Dyspnoea—Sibutramine—obesity	0.000866	0.00146	CcSEcCtD
Dicyclomine—Fatigue—Orlistat—obesity	0.000865	0.00146	CcSEcCtD
Dicyclomine—Dry mouth—Bupropion—obesity	0.000864	0.00146	CcSEcCtD
Dicyclomine—Somnolence—Sibutramine—obesity	0.000863	0.00146	CcSEcCtD
Dicyclomine—Pain—Orlistat—obesity	0.000858	0.00145	CcSEcCtD
Dicyclomine—Dyspepsia—Sibutramine—obesity	0.000855	0.00144	CcSEcCtD
Dicyclomine—Confusional state—Bupropion—obesity	0.000853	0.00144	CcSEcCtD
Dicyclomine—CYP1A1—respiratory system—obesity	0.000851	0.0521	CbGeAlD
Dicyclomine—Anaphylactic shock—Bupropion—obesity	0.000846	0.00143	CcSEcCtD
Dicyclomine—Oedema—Bupropion—obesity	0.000846	0.00143	CcSEcCtD
Dicyclomine—Decreased appetite—Sibutramine—obesity	0.000844	0.00142	CcSEcCtD
Dicyclomine—Gastrointestinal disorder—Sibutramine—obesity	0.000838	0.00141	CcSEcCtD
Dicyclomine—Shock—Bupropion—obesity	0.000833	0.0014	CcSEcCtD
Dicyclomine—Pain—Sibutramine—obesity	0.00083	0.0014	CcSEcCtD
Dicyclomine—Constipation—Sibutramine—obesity	0.00083	0.0014	CcSEcCtD
Dicyclomine—Nervous system disorder—Bupropion—obesity	0.00083	0.0014	CcSEcCtD
Dicyclomine—Feeling abnormal—Orlistat—obesity	0.000827	0.00139	CcSEcCtD
Dicyclomine—Tachycardia—Bupropion—obesity	0.000826	0.00139	CcSEcCtD
Dicyclomine—Gastrointestinal pain—Orlistat—obesity	0.00082	0.00138	CcSEcCtD
Dicyclomine—Anorexia—Bupropion—obesity	0.000807	0.00136	CcSEcCtD
Dicyclomine—Feeling abnormal—Sibutramine—obesity	0.0008	0.00135	CcSEcCtD
Dicyclomine—Urticaria—Orlistat—obesity	0.000797	0.00134	CcSEcCtD
Dicyclomine—Gastrointestinal pain—Sibutramine—obesity	0.000794	0.00134	CcSEcCtD
Dicyclomine—Abdominal pain—Orlistat—obesity	0.000793	0.00134	CcSEcCtD
Dicyclomine—Urticaria—Sibutramine—obesity	0.000771	0.0013	CcSEcCtD
Dicyclomine—CHRM3—adipose tissue—obesity	0.000768	0.047	CbGeAlD
Dicyclomine—Abdominal pain—Sibutramine—obesity	0.000768	0.00129	CcSEcCtD
Dicyclomine—Insomnia—Bupropion—obesity	0.000766	0.00129	CcSEcCtD
Dicyclomine—Paraesthesia—Bupropion—obesity	0.00076	0.00128	CcSEcCtD
Dicyclomine—Hypoaesthesia—Topiramate—obesity	0.000755	0.00127	CcSEcCtD
Dicyclomine—Hallucination—Topiramate—obesity	0.000755	0.00127	CcSEcCtD
Dicyclomine—Dyspnoea—Bupropion—obesity	0.000755	0.00127	CcSEcCtD
Dicyclomine—Somnolence—Bupropion—obesity	0.000753	0.00127	CcSEcCtD
Dicyclomine—Dyspepsia—Bupropion—obesity	0.000745	0.00126	CcSEcCtD
Dicyclomine—Hypersensitivity—Orlistat—obesity	0.000739	0.00125	CcSEcCtD
Dicyclomine—Decreased appetite—Bupropion—obesity	0.000736	0.00124	CcSEcCtD
Dicyclomine—CHRM2—endocrine gland—obesity	0.000733	0.0449	CbGeAlD
Dicyclomine—Gastrointestinal disorder—Bupropion—obesity	0.000731	0.00123	CcSEcCtD
Dicyclomine—Fatigue—Bupropion—obesity	0.00073	0.00123	CcSEcCtD
Dicyclomine—Pain—Bupropion—obesity	0.000724	0.00122	CcSEcCtD
Dicyclomine—Constipation—Bupropion—obesity	0.000724	0.00122	CcSEcCtD
Dicyclomine—CHRM3—digestive system—obesity	0.000723	0.0443	CbGeAlD
Dicyclomine—Asthenia—Orlistat—obesity	0.00072	0.00121	CcSEcCtD
Dicyclomine—Hypersensitivity—Sibutramine—obesity	0.000715	0.00121	CcSEcCtD
Dicyclomine—Pruritus—Orlistat—obesity	0.00071	0.0012	CcSEcCtD
Dicyclomine—Eye disorder—Topiramate—obesity	0.000709	0.0012	CcSEcCtD
Dicyclomine—Cardiac disorder—Topiramate—obesity	0.000704	0.00119	CcSEcCtD
Dicyclomine—Feeling abnormal—Bupropion—obesity	0.000698	0.00118	CcSEcCtD
Dicyclomine—Asthenia—Sibutramine—obesity	0.000697	0.00118	CcSEcCtD
Dicyclomine—Gastrointestinal pain—Bupropion—obesity	0.000692	0.00117	CcSEcCtD
Dicyclomine—Pruritus—Sibutramine—obesity	0.000687	0.00116	CcSEcCtD
Dicyclomine—Immune system disorder—Topiramate—obesity	0.000686	0.00116	CcSEcCtD
Dicyclomine—Mediastinal disorder—Topiramate—obesity	0.000684	0.00115	CcSEcCtD
Dicyclomine—Urticaria—Bupropion—obesity	0.000672	0.00113	CcSEcCtD
Dicyclomine—Abdominal pain—Bupropion—obesity	0.000669	0.00113	CcSEcCtD
Dicyclomine—CHRM1—endocrine gland—obesity	0.000667	0.0409	CbGeAlD
Dicyclomine—Mental disorder—Topiramate—obesity	0.000665	0.00112	CcSEcCtD
Dicyclomine—Dizziness—Orlistat—obesity	0.000663	0.00112	CcSEcCtD
Dicyclomine—Erythema—Topiramate—obesity	0.000661	0.00111	CcSEcCtD
Dicyclomine—Tension—Topiramate—obesity	0.000648	0.00109	CcSEcCtD
Dicyclomine—Dizziness—Sibutramine—obesity	0.000642	0.00108	CcSEcCtD
Dicyclomine—Nervousness—Topiramate—obesity	0.000642	0.00108	CcSEcCtD
Dicyclomine—Vomiting—Orlistat—obesity	0.000638	0.00108	CcSEcCtD
Dicyclomine—Rash—Orlistat—obesity	0.000633	0.00107	CcSEcCtD
Dicyclomine—Dermatitis—Orlistat—obesity	0.000632	0.00107	CcSEcCtD
Dicyclomine—Headache—Orlistat—obesity	0.000629	0.00106	CcSEcCtD
Dicyclomine—Hypersensitivity—Bupropion—obesity	0.000624	0.00105	CcSEcCtD
Dicyclomine—Vision blurred—Topiramate—obesity	0.000623	0.00105	CcSEcCtD
Dicyclomine—Vomiting—Sibutramine—obesity	0.000617	0.00104	CcSEcCtD
Dicyclomine—Ill-defined disorder—Topiramate—obesity	0.000613	0.00103	CcSEcCtD
Dicyclomine—Rash—Sibutramine—obesity	0.000612	0.00103	CcSEcCtD
Dicyclomine—Dermatitis—Sibutramine—obesity	0.000612	0.00103	CcSEcCtD
Dicyclomine—Headache—Sibutramine—obesity	0.000608	0.00103	CcSEcCtD
Dicyclomine—Asthenia—Bupropion—obesity	0.000607	0.00102	CcSEcCtD
Dicyclomine—Agitation—Topiramate—obesity	0.000607	0.00102	CcSEcCtD
Dicyclomine—Pruritus—Bupropion—obesity	0.000599	0.00101	CcSEcCtD
Dicyclomine—CHRM3—endocrine gland—obesity	0.000597	0.0366	CbGeAlD
Dicyclomine—Nausea—Orlistat—obesity	0.000596	0.00101	CcSEcCtD
Dicyclomine—Malaise—Topiramate—obesity	0.000596	0.00101	CcSEcCtD
Dicyclomine—Syncope—Topiramate—obesity	0.000593	0.001	CcSEcCtD
Dicyclomine—Palpitations—Topiramate—obesity	0.000584	0.000985	CcSEcCtD
Dicyclomine—Loss of consciousness—Topiramate—obesity	0.000581	0.00098	CcSEcCtD
Dicyclomine—Nausea—Sibutramine—obesity	0.000577	0.000973	CcSEcCtD
Dicyclomine—CYP1A1—adipose tissue—obesity	0.000575	0.0352	CbGeAlD
Dicyclomine—Hypertension—Topiramate—obesity	0.00057	0.000962	CcSEcCtD
Dicyclomine—Dizziness—Bupropion—obesity	0.00056	0.000944	CcSEcCtD
Dicyclomine—Discomfort—Topiramate—obesity	0.000556	0.000938	CcSEcCtD
Dicyclomine—Dry mouth—Topiramate—obesity	0.00055	0.000928	CcSEcCtD
Dicyclomine—Confusional state—Topiramate—obesity	0.000544	0.000917	CcSEcCtD
Dicyclomine—CYP1A1—digestive system—obesity	0.000541	0.0331	CbGeAlD
Dicyclomine—Oedema—Topiramate—obesity	0.000539	0.00091	CcSEcCtD
Dicyclomine—Vomiting—Bupropion—obesity	0.000538	0.000908	CcSEcCtD
Dicyclomine—Rash—Bupropion—obesity	0.000534	0.0009	CcSEcCtD
Dicyclomine—Dermatitis—Bupropion—obesity	0.000533	0.000899	CcSEcCtD
Dicyclomine—Shock—Topiramate—obesity	0.000531	0.000895	CcSEcCtD
Dicyclomine—Headache—Bupropion—obesity	0.00053	0.000895	CcSEcCtD
Dicyclomine—Nervous system disorder—Topiramate—obesity	0.000529	0.000892	CcSEcCtD
Dicyclomine—Tachycardia—Topiramate—obesity	0.000526	0.000888	CcSEcCtD
Dicyclomine—Anorexia—Topiramate—obesity	0.000514	0.000867	CcSEcCtD
Dicyclomine—Nausea—Bupropion—obesity	0.000503	0.000848	CcSEcCtD
Dicyclomine—Insomnia—Topiramate—obesity	0.000488	0.000823	CcSEcCtD
Dicyclomine—Paraesthesia—Topiramate—obesity	0.000484	0.000817	CcSEcCtD
Dicyclomine—Dyspnoea—Topiramate—obesity	0.000481	0.000811	CcSEcCtD
Dicyclomine—Somnolence—Topiramate—obesity	0.000479	0.000809	CcSEcCtD
Dicyclomine—Dyspepsia—Topiramate—obesity	0.000475	0.000801	CcSEcCtD
Dicyclomine—Decreased appetite—Topiramate—obesity	0.000469	0.000791	CcSEcCtD
Dicyclomine—Gastrointestinal disorder—Topiramate—obesity	0.000466	0.000785	CcSEcCtD
Dicyclomine—Fatigue—Topiramate—obesity	0.000465	0.000784	CcSEcCtD
Dicyclomine—Constipation—Topiramate—obesity	0.000461	0.000778	CcSEcCtD
Dicyclomine—Pain—Topiramate—obesity	0.000461	0.000778	CcSEcCtD
Dicyclomine—CYP1A1—endocrine gland—obesity	0.000447	0.0274	CbGeAlD
Dicyclomine—Feeling abnormal—Topiramate—obesity	0.000444	0.00075	CcSEcCtD
Dicyclomine—Gastrointestinal pain—Topiramate—obesity	0.000441	0.000744	CcSEcCtD
Dicyclomine—Urticaria—Topiramate—obesity	0.000428	0.000723	CcSEcCtD
Dicyclomine—Abdominal pain—Topiramate—obesity	0.000426	0.000719	CcSEcCtD
Dicyclomine—CYP1A1—liver—obesity	0.000403	0.0247	CbGeAlD
Dicyclomine—Hypersensitivity—Topiramate—obesity	0.000397	0.00067	CcSEcCtD
Dicyclomine—Asthenia—Topiramate—obesity	0.000387	0.000653	CcSEcCtD
Dicyclomine—Pruritus—Topiramate—obesity	0.000382	0.000644	CcSEcCtD
Dicyclomine—Dizziness—Topiramate—obesity	0.000357	0.000602	CcSEcCtD
Dicyclomine—Vomiting—Topiramate—obesity	0.000343	0.000578	CcSEcCtD
Dicyclomine—Rash—Topiramate—obesity	0.00034	0.000574	CcSEcCtD
Dicyclomine—Dermatitis—Topiramate—obesity	0.00034	0.000573	CcSEcCtD
Dicyclomine—Headache—Topiramate—obesity	0.000338	0.00057	CcSEcCtD
Dicyclomine—Nausea—Topiramate—obesity	0.00032	0.00054	CcSEcCtD
Dicyclomine—CHRM1—Signaling Pathways—STK11—obesity	3.45e-05	8.84e-05	CbGpPWpGaD
Dicyclomine—CHRM3—Signaling Pathways—STK11—obesity	3.44e-05	8.81e-05	CbGpPWpGaD
Dicyclomine—CHRM1—Signaling by GPCR—CCL2—obesity	3.44e-05	8.8e-05	CbGpPWpGaD
Dicyclomine—CHRM3—Metabolism—LPL—obesity	3.44e-05	8.79e-05	CbGpPWpGaD
Dicyclomine—CYP1A1—Metabolism—CYCS—obesity	3.43e-05	8.78e-05	CbGpPWpGaD
Dicyclomine—CHRM3—Signaling by GPCR—CCL2—obesity	3.43e-05	8.77e-05	CbGpPWpGaD
Dicyclomine—CHRM1—Signaling Pathways—PLG—obesity	3.41e-05	8.74e-05	CbGpPWpGaD
Dicyclomine—CHRM1—GPCR downstream signaling—RHOA—obesity	3.41e-05	8.72e-05	CbGpPWpGaD
Dicyclomine—CHRM2—Signaling Pathways—STK11—obesity	3.41e-05	8.72e-05	CbGpPWpGaD
Dicyclomine—CHRM3—Signaling Pathways—PLG—obesity	3.4e-05	8.71e-05	CbGpPWpGaD
Dicyclomine—CHRM3—GPCR downstream signaling—RHOA—obesity	3.4e-05	8.69e-05	CbGpPWpGaD
Dicyclomine—CHRM2—Signaling by GPCR—CCL2—obesity	3.39e-05	8.68e-05	CbGpPWpGaD
Dicyclomine—CHRM1—Signaling by GPCR—AKT2—obesity	3.38e-05	8.64e-05	CbGpPWpGaD
Dicyclomine—CHRM1—GPCR downstream signaling—PIK3R1—obesity	3.37e-05	8.63e-05	CbGpPWpGaD
Dicyclomine—CHRM2—Signaling Pathways—PLG—obesity	3.37e-05	8.62e-05	CbGpPWpGaD
Dicyclomine—CYP1A1—Metabolism—GGT1—obesity	3.37e-05	8.62e-05	CbGpPWpGaD
Dicyclomine—CYP1A1—Metabolism—GOT1—obesity	3.37e-05	8.62e-05	CbGpPWpGaD
Dicyclomine—CHRM3—Signaling by GPCR—AKT2—obesity	3.37e-05	8.61e-05	CbGpPWpGaD
Dicyclomine—CHRM2—GPCR downstream signaling—RHOA—obesity	3.37e-05	8.61e-05	CbGpPWpGaD
Dicyclomine—CHRM3—GPCR downstream signaling—PIK3R1—obesity	3.36e-05	8.6e-05	CbGpPWpGaD
Dicyclomine—CHRM3—Metabolism—GPX1—obesity	3.35e-05	8.58e-05	CbGpPWpGaD
Dicyclomine—CHRM2—Signaling by GPCR—AKT2—obesity	3.33e-05	8.53e-05	CbGpPWpGaD
Dicyclomine—CHRM1—Signaling Pathways—FOXO3—obesity	3.33e-05	8.53e-05	CbGpPWpGaD
Dicyclomine—CHRM2—GPCR downstream signaling—PIK3R1—obesity	3.33e-05	8.52e-05	CbGpPWpGaD
Dicyclomine—CHRM1—Signaling Pathways—ADRB2—obesity	3.32e-05	8.51e-05	CbGpPWpGaD
Dicyclomine—CHRM3—Signaling Pathways—FOXO3—obesity	3.32e-05	8.5e-05	CbGpPWpGaD
Dicyclomine—CYP1A1—Metabolism—NCOA1—obesity	3.32e-05	8.49e-05	CbGpPWpGaD
Dicyclomine—CHRM3—Signaling Pathways—ADRB2—obesity	3.31e-05	8.48e-05	CbGpPWpGaD
Dicyclomine—CHRM2—Signaling Pathways—FOXO3—obesity	3.29e-05	8.42e-05	CbGpPWpGaD
Dicyclomine—CHRM2—Signaling Pathways—ADRB2—obesity	3.28e-05	8.4e-05	CbGpPWpGaD
Dicyclomine—CHRM1—Signaling Pathways—SOCS1—obesity	3.27e-05	8.38e-05	CbGpPWpGaD
Dicyclomine—CYP1A1—Metabolism—STK11—obesity	3.27e-05	8.37e-05	CbGpPWpGaD
Dicyclomine—CYP1A1—Metabolism—CYP19A1—obesity	3.27e-05	8.37e-05	CbGpPWpGaD
Dicyclomine—CHRM3—Metabolism—CD36—obesity	3.26e-05	8.35e-05	CbGpPWpGaD
Dicyclomine—CHRM3—Signaling Pathways—SOCS1—obesity	3.26e-05	8.35e-05	CbGpPWpGaD
Dicyclomine—CHRM1—Signaling by GPCR—PIK3CD—obesity	3.24e-05	8.3e-05	CbGpPWpGaD
Dicyclomine—CHRM3—Signaling by GPCR—PIK3CD—obesity	3.23e-05	8.28e-05	CbGpPWpGaD
Dicyclomine—CHRM1—Signaling Pathways—SOCS3—obesity	3.23e-05	8.27e-05	CbGpPWpGaD
Dicyclomine—CHRM2—Signaling Pathways—SOCS1—obesity	3.23e-05	8.27e-05	CbGpPWpGaD
Dicyclomine—CHRM3—Signaling Pathways—SOCS3—obesity	3.22e-05	8.25e-05	CbGpPWpGaD
Dicyclomine—CHRM2—Signaling by GPCR—PIK3CD—obesity	3.2e-05	8.19e-05	CbGpPWpGaD
Dicyclomine—CHRM2—Signaling Pathways—SOCS3—obesity	3.19e-05	8.17e-05	CbGpPWpGaD
Dicyclomine—CHRM1—Signaling Pathways—GNB3—obesity	3.17e-05	8.1e-05	CbGpPWpGaD
Dicyclomine—CHRM3—Signaling Pathways—GNB3—obesity	3.16e-05	8.07e-05	CbGpPWpGaD
Dicyclomine—CHRM2—Signaling Pathways—GNB3—obesity	3.13e-05	8e-05	CbGpPWpGaD
Dicyclomine—CHRM1—Signaling by GPCR—TYK2—obesity	3.12e-05	7.99e-05	CbGpPWpGaD
Dicyclomine—CHRM1—GPCR downstream signaling—PIK3CB—obesity	3.11e-05	7.97e-05	CbGpPWpGaD
Dicyclomine—CHRM3—Signaling by GPCR—TYK2—obesity	3.11e-05	7.96e-05	CbGpPWpGaD
Dicyclomine—CHRM1—Signaling Pathways—IGF2—obesity	3.11e-05	7.96e-05	CbGpPWpGaD
Dicyclomine—CHRM3—GPCR downstream signaling—PIK3CB—obesity	3.1e-05	7.94e-05	CbGpPWpGaD
Dicyclomine—CHRM3—Signaling Pathways—IGF2—obesity	3.1e-05	7.93e-05	CbGpPWpGaD
Dicyclomine—CHRM1—Signaling by GPCR—RHOA—obesity	3.1e-05	7.92e-05	CbGpPWpGaD
Dicyclomine—CHRM3—Metabolism—MTHFR—obesity	3.09e-05	7.92e-05	CbGpPWpGaD
Dicyclomine—CHRM3—Signaling by GPCR—RHOA—obesity	3.09e-05	7.9e-05	CbGpPWpGaD
Dicyclomine—CHRM1—Signaling Pathways—GNAS—obesity	3.08e-05	7.89e-05	CbGpPWpGaD
Dicyclomine—CHRM2—Signaling by GPCR—TYK2—obesity	3.08e-05	7.88e-05	CbGpPWpGaD
Dicyclomine—CHRM2—GPCR downstream signaling—PIK3CB—obesity	3.07e-05	7.87e-05	CbGpPWpGaD
Dicyclomine—CHRM3—Signaling Pathways—GNAS—obesity	3.07e-05	7.86e-05	CbGpPWpGaD
Dicyclomine—CHRM2—Signaling Pathways—IGF2—obesity	3.07e-05	7.85e-05	CbGpPWpGaD
Dicyclomine—CHRM1—Signaling by GPCR—PIK3R1—obesity	3.06e-05	7.84e-05	CbGpPWpGaD
Dicyclomine—CHRM2—Signaling by GPCR—RHOA—obesity	3.06e-05	7.82e-05	CbGpPWpGaD
Dicyclomine—CHRM3—Signaling by GPCR—PIK3R1—obesity	3.05e-05	7.81e-05	CbGpPWpGaD
Dicyclomine—CHRM2—Signaling Pathways—GNAS—obesity	3.04e-05	7.79e-05	CbGpPWpGaD
Dicyclomine—CYP1A1—Metabolism—COMT—obesity	3.04e-05	7.78e-05	CbGpPWpGaD
Dicyclomine—CHRM3—Metabolism—PPARA—obesity	3.04e-05	7.77e-05	CbGpPWpGaD
Dicyclomine—CHRM2—Signaling by GPCR—PIK3R1—obesity	3.02e-05	7.74e-05	CbGpPWpGaD
Dicyclomine—CHRM1—Signaling Pathways—APOB—obesity	3.02e-05	7.72e-05	CbGpPWpGaD
Dicyclomine—CHRM3—Signaling Pathways—APOB—obesity	3.01e-05	7.7e-05	CbGpPWpGaD
Dicyclomine—CYP1A1—Metabolism—PPARGC1A—obesity	3e-05	7.67e-05	CbGpPWpGaD
Dicyclomine—CYP1A1—Metabolism—GNB3—obesity	3e-05	7.67e-05	CbGpPWpGaD
Dicyclomine—CYP1A1—Metabolism—HMOX1—obesity	2.98e-05	7.64e-05	CbGpPWpGaD
Dicyclomine—CHRM2—Signaling Pathways—APOB—obesity	2.98e-05	7.62e-05	CbGpPWpGaD
Dicyclomine—CHRM1—Signaling Pathways—CCL5—obesity	2.95e-05	7.54e-05	CbGpPWpGaD
Dicyclomine—CHRM3—Metabolism—AGT—obesity	2.94e-05	7.52e-05	CbGpPWpGaD
Dicyclomine—CHRM3—Signaling Pathways—CCL5—obesity	2.94e-05	7.52e-05	CbGpPWpGaD
Dicyclomine—CYP1A1—Metabolism—GNAS—obesity	2.92e-05	7.47e-05	CbGpPWpGaD
Dicyclomine—CHRM2—Signaling Pathways—CCL5—obesity	2.91e-05	7.44e-05	CbGpPWpGaD
Dicyclomine—CHRM1—Signaling Pathways—LPL—obesity	2.88e-05	7.37e-05	CbGpPWpGaD
Dicyclomine—CHRM3—Metabolism—APOE—obesity	2.88e-05	7.37e-05	CbGpPWpGaD
Dicyclomine—CHRM3—Signaling Pathways—LPL—obesity	2.87e-05	7.35e-05	CbGpPWpGaD
Dicyclomine—CHRM1—Signaling Pathways—FOXO1—obesity	2.86e-05	7.32e-05	CbGpPWpGaD
Dicyclomine—CYP1A1—Metabolism—APOB—obesity	2.86e-05	7.31e-05	CbGpPWpGaD
Dicyclomine—CHRM1—Signaling Pathways—RPS6KB1—obesity	2.86e-05	7.31e-05	CbGpPWpGaD
Dicyclomine—CHRM3—Metabolism—CAV1—obesity	2.85e-05	7.3e-05	CbGpPWpGaD
Dicyclomine—CHRM3—Signaling Pathways—FOXO1—obesity	2.85e-05	7.3e-05	CbGpPWpGaD
Dicyclomine—CHRM3—Signaling Pathways—RPS6KB1—obesity	2.85e-05	7.28e-05	CbGpPWpGaD
Dicyclomine—CHRM3—Metabolism—APOA1—obesity	2.85e-05	7.28e-05	CbGpPWpGaD
Dicyclomine—CHRM2—Signaling Pathways—LPL—obesity	2.85e-05	7.28e-05	CbGpPWpGaD
Dicyclomine—CHRM1—Signaling by GPCR—PIK3CB—obesity	2.83e-05	7.24e-05	CbGpPWpGaD
Dicyclomine—CHRM2—Signaling Pathways—FOXO1—obesity	2.82e-05	7.23e-05	CbGpPWpGaD
Dicyclomine—CHRM2—Signaling Pathways—RPS6KB1—obesity	2.82e-05	7.21e-05	CbGpPWpGaD
Dicyclomine—CHRM3—Signaling by GPCR—PIK3CB—obesity	2.82e-05	7.21e-05	CbGpPWpGaD
Dicyclomine—CHRM2—Signaling by GPCR—PIK3CB—obesity	2.79e-05	7.14e-05	CbGpPWpGaD
Dicyclomine—CYP1A1—Metabolism—LPL—obesity	2.73e-05	6.98e-05	CbGpPWpGaD
Dicyclomine—CYP1A1—Metabolism—GPX1—obesity	2.66e-05	6.81e-05	CbGpPWpGaD
Dicyclomine—CHRM1—Signaling Pathways—PRKCD—obesity	2.66e-05	6.79e-05	CbGpPWpGaD
Dicyclomine—CHRM3—Signaling Pathways—PRKCD—obesity	2.65e-05	6.77e-05	CbGpPWpGaD
Dicyclomine—CHRM2—Signaling Pathways—PRKCD—obesity	2.62e-05	6.71e-05	CbGpPWpGaD
Dicyclomine—CHRM3—Metabolism—PIK3CG—obesity	2.6e-05	6.65e-05	CbGpPWpGaD
Dicyclomine—CHRM1—Signaling Pathways—HTR2A—obesity	2.6e-05	6.65e-05	CbGpPWpGaD
Dicyclomine—CHRM1—Signaling Pathways—C3—obesity	2.6e-05	6.64e-05	CbGpPWpGaD
Dicyclomine—CYP1A1—Metabolism—CD36—obesity	2.59e-05	6.64e-05	CbGpPWpGaD
Dicyclomine—CHRM3—Signaling Pathways—HTR2A—obesity	2.59e-05	6.63e-05	CbGpPWpGaD
Dicyclomine—CHRM3—Signaling Pathways—C3—obesity	2.59e-05	6.62e-05	CbGpPWpGaD
Dicyclomine—CHRM2—Signaling Pathways—HTR2A—obesity	2.57e-05	6.56e-05	CbGpPWpGaD
Dicyclomine—CHRM2—Signaling Pathways—C3—obesity	2.56e-05	6.55e-05	CbGpPWpGaD
Dicyclomine—CHRM3—Metabolism—PPARG—obesity	2.51e-05	6.42e-05	CbGpPWpGaD
Dicyclomine—CHRM3—Metabolism—POMC—obesity	2.47e-05	6.33e-05	CbGpPWpGaD
Dicyclomine—CHRM1—Signaling Pathways—IRS2—obesity	2.47e-05	6.32e-05	CbGpPWpGaD
Dicyclomine—CHRM1—Signaling Pathways—AGT—obesity	2.47e-05	6.31e-05	CbGpPWpGaD
Dicyclomine—CHRM3—Signaling Pathways—IRS2—obesity	2.46e-05	6.3e-05	CbGpPWpGaD
Dicyclomine—CHRM3—Metabolism—INS—obesity	2.46e-05	6.3e-05	CbGpPWpGaD
Dicyclomine—CHRM3—Signaling Pathways—AGT—obesity	2.46e-05	6.29e-05	CbGpPWpGaD
Dicyclomine—CYP1A1—Metabolism—MTHFR—obesity	2.46e-05	6.29e-05	CbGpPWpGaD
Dicyclomine—CHRM2—Signaling Pathways—IRS2—obesity	2.44e-05	6.24e-05	CbGpPWpGaD
Dicyclomine—CHRM2—Signaling Pathways—AGT—obesity	2.43e-05	6.23e-05	CbGpPWpGaD
Dicyclomine—CHRM1—Signaling Pathways—LEP—obesity	2.42e-05	6.18e-05	CbGpPWpGaD
Dicyclomine—CHRM1—Signaling Pathways—APOE—obesity	2.42e-05	6.18e-05	CbGpPWpGaD
Dicyclomine—CYP1A1—Metabolism—PPARA—obesity	2.41e-05	6.17e-05	CbGpPWpGaD
Dicyclomine—CHRM3—Signaling Pathways—LEP—obesity	2.41e-05	6.16e-05	CbGpPWpGaD
Dicyclomine—CHRM3—Signaling Pathways—APOE—obesity	2.41e-05	6.16e-05	CbGpPWpGaD
Dicyclomine—CHRM1—Signaling Pathways—CAV1—obesity	2.39e-05	6.12e-05	CbGpPWpGaD
Dicyclomine—CHRM1—Signaling Pathways—APOA1—obesity	2.39e-05	6.11e-05	CbGpPWpGaD
Dicyclomine—CHRM3—Signaling Pathways—CAV1—obesity	2.39e-05	6.1e-05	CbGpPWpGaD
Dicyclomine—CHRM2—Signaling Pathways—LEP—obesity	2.38e-05	6.1e-05	CbGpPWpGaD
Dicyclomine—CHRM2—Signaling Pathways—APOE—obesity	2.38e-05	6.1e-05	CbGpPWpGaD
Dicyclomine—CHRM3—Signaling Pathways—APOA1—obesity	2.38e-05	6.09e-05	CbGpPWpGaD
Dicyclomine—CHRM2—Signaling Pathways—CAV1—obesity	2.36e-05	6.05e-05	CbGpPWpGaD
Dicyclomine—CHRM2—Signaling Pathways—APOA1—obesity	2.36e-05	6.03e-05	CbGpPWpGaD
Dicyclomine—CYP1A1—Metabolism—AGT—obesity	2.34e-05	5.97e-05	CbGpPWpGaD
Dicyclomine—CHRM1—Signaling Pathways—ESR1—obesity	2.31e-05	5.9e-05	CbGpPWpGaD
Dicyclomine—CHRM3—Signaling Pathways—ESR1—obesity	2.3e-05	5.88e-05	CbGpPWpGaD
Dicyclomine—CYP1A1—Metabolism—APOE—obesity	2.29e-05	5.85e-05	CbGpPWpGaD
Dicyclomine—CHRM3—Metabolism—PIK3CD—obesity	2.29e-05	5.85e-05	CbGpPWpGaD
Dicyclomine—CHRM1—Signaling Pathways—PRKCB—obesity	2.28e-05	5.83e-05	CbGpPWpGaD
Dicyclomine—CHRM1—Signaling Pathways—F2—obesity	2.28e-05	5.83e-05	CbGpPWpGaD
Dicyclomine—CHRM2—Signaling Pathways—ESR1—obesity	2.28e-05	5.83e-05	CbGpPWpGaD
Dicyclomine—CHRM3—Signaling Pathways—PRKCB—obesity	2.27e-05	5.81e-05	CbGpPWpGaD
Dicyclomine—CHRM3—Signaling Pathways—F2—obesity	2.27e-05	5.81e-05	CbGpPWpGaD
Dicyclomine—CYP1A1—Metabolism—CAV1—obesity	2.27e-05	5.8e-05	CbGpPWpGaD
Dicyclomine—CYP1A1—Metabolism—APOA1—obesity	2.26e-05	5.79e-05	CbGpPWpGaD
Dicyclomine—CHRM3—Metabolism—ALB—obesity	2.26e-05	5.77e-05	CbGpPWpGaD
Dicyclomine—CHRM1—Signaling Pathways—BAD—obesity	2.25e-05	5.76e-05	CbGpPWpGaD
Dicyclomine—CHRM2—Signaling Pathways—F2—obesity	2.25e-05	5.75e-05	CbGpPWpGaD
Dicyclomine—CHRM2—Signaling Pathways—PRKCB—obesity	2.25e-05	5.75e-05	CbGpPWpGaD
Dicyclomine—CHRM3—Signaling Pathways—BAD—obesity	2.24e-05	5.74e-05	CbGpPWpGaD
Dicyclomine—CHRM2—Signaling Pathways—BAD—obesity	2.22e-05	5.69e-05	CbGpPWpGaD
Dicyclomine—CHRM1—Signaling Pathways—PIK3CG—obesity	2.18e-05	5.58e-05	CbGpPWpGaD
Dicyclomine—CHRM3—Signaling Pathways—PIK3CG—obesity	2.17e-05	5.56e-05	CbGpPWpGaD
Dicyclomine—CYP1A1—Metabolism of lipids and lipoproteins—PIK3CA—obesity	2.17e-05	5.54e-05	CbGpPWpGaD
Dicyclomine—CHRM3—Metabolism—PIK3R1—obesity	2.16e-05	5.52e-05	CbGpPWpGaD
Dicyclomine—CHRM3—Metabolism—NOS3—obesity	2.16e-05	5.52e-05	CbGpPWpGaD
Dicyclomine—CHRM1—Signaling Pathways—IRS1—obesity	2.16e-05	5.51e-05	CbGpPWpGaD
Dicyclomine—CHRM2—Signaling Pathways—PIK3CG—obesity	2.15e-05	5.51e-05	CbGpPWpGaD
Dicyclomine—CHRM3—Signaling Pathways—IRS1—obesity	2.15e-05	5.5e-05	CbGpPWpGaD
Dicyclomine—CHRM2—Signaling Pathways—IRS1—obesity	2.13e-05	5.44e-05	CbGpPWpGaD
Dicyclomine—CHRM1—Signaling Pathways—POMC—obesity	2.08e-05	5.31e-05	CbGpPWpGaD
Dicyclomine—CHRM3—Signaling Pathways—POMC—obesity	2.07e-05	5.29e-05	CbGpPWpGaD
Dicyclomine—CYP1A1—Metabolism—PIK3CG—obesity	2.06e-05	5.28e-05	CbGpPWpGaD
Dicyclomine—CHRM1—Signaling Pathways—INS—obesity	2.06e-05	5.28e-05	CbGpPWpGaD
Dicyclomine—CHRM3—Signaling Pathways—INS—obesity	2.06e-05	5.26e-05	CbGpPWpGaD
Dicyclomine—CHRM2—Signaling Pathways—POMC—obesity	2.05e-05	5.24e-05	CbGpPWpGaD
Dicyclomine—CHRM2—Signaling Pathways—INS—obesity	2.04e-05	5.21e-05	CbGpPWpGaD
Dicyclomine—CHRM1—Signaling Pathways—CCL2—obesity	2.03e-05	5.2e-05	CbGpPWpGaD
Dicyclomine—CHRM3—Signaling Pathways—CCL2—obesity	2.02e-05	5.18e-05	CbGpPWpGaD
Dicyclomine—CHRM2—Signaling Pathways—CCL2—obesity	2e-05	5.13e-05	CbGpPWpGaD
Dicyclomine—CHRM1—Signaling Pathways—IGF1—obesity	2e-05	5.11e-05	CbGpPWpGaD
Dicyclomine—CHRM1—Signaling Pathways—AKT2—obesity	1.99e-05	5.1e-05	CbGpPWpGaD
Dicyclomine—CYP1A1—Metabolism—PPARG—obesity	1.99e-05	5.1e-05	CbGpPWpGaD
Dicyclomine—CHRM3—Metabolism—PIK3CB—obesity	1.99e-05	5.1e-05	CbGpPWpGaD
Dicyclomine—CHRM3—Signaling Pathways—IGF1—obesity	1.99e-05	5.09e-05	CbGpPWpGaD
Dicyclomine—CHRM3—Signaling Pathways—AKT2—obesity	1.99e-05	5.09e-05	CbGpPWpGaD
Dicyclomine—CHRM3—Metabolism—PTGS2—obesity	1.97e-05	5.05e-05	CbGpPWpGaD
Dicyclomine—CHRM2—Signaling Pathways—IGF1—obesity	1.97e-05	5.04e-05	CbGpPWpGaD
Dicyclomine—CHRM2—Signaling Pathways—AKT2—obesity	1.97e-05	5.04e-05	CbGpPWpGaD
Dicyclomine—CYP1A1—Metabolism—POMC—obesity	1.97e-05	5.03e-05	CbGpPWpGaD
Dicyclomine—CYP1A1—Metabolism—INS—obesity	1.95e-05	5e-05	CbGpPWpGaD
Dicyclomine—CHRM1—Signaling Pathways—PIK3CD—obesity	1.92e-05	4.9e-05	CbGpPWpGaD
Dicyclomine—CHRM3—Signaling Pathways—PIK3CD—obesity	1.91e-05	4.89e-05	CbGpPWpGaD
Dicyclomine—CHRM1—GPCR downstream signaling—PIK3CA—obesity	1.9e-05	4.86e-05	CbGpPWpGaD
Dicyclomine—CHRM1—Signaling Pathways—SERPINE1—obesity	1.9e-05	4.85e-05	CbGpPWpGaD
Dicyclomine—CHRM3—GPCR downstream signaling—PIK3CA—obesity	1.89e-05	4.84e-05	CbGpPWpGaD
Dicyclomine—CHRM2—Signaling Pathways—PIK3CD—obesity	1.89e-05	4.84e-05	CbGpPWpGaD
Dicyclomine—CHRM3—Signaling Pathways—SERPINE1—obesity	1.89e-05	4.83e-05	CbGpPWpGaD
Dicyclomine—CHRM2—GPCR downstream signaling—PIK3CA—obesity	1.87e-05	4.79e-05	CbGpPWpGaD
Dicyclomine—CHRM2—Signaling Pathways—SERPINE1—obesity	1.87e-05	4.79e-05	CbGpPWpGaD
Dicyclomine—CHRM1—Signaling Pathways—TYK2—obesity	1.84e-05	4.72e-05	CbGpPWpGaD
Dicyclomine—CHRM3—Signaling Pathways—TYK2—obesity	1.84e-05	4.7e-05	CbGpPWpGaD
Dicyclomine—CHRM1—Signaling Pathways—RHOA—obesity	1.83e-05	4.68e-05	CbGpPWpGaD
Dicyclomine—CHRM3—Signaling Pathways—RHOA—obesity	1.82e-05	4.66e-05	CbGpPWpGaD
Dicyclomine—CHRM2—Signaling Pathways—TYK2—obesity	1.82e-05	4.66e-05	CbGpPWpGaD
Dicyclomine—CYP1A1—Metabolism—PIK3CD—obesity	1.82e-05	4.64e-05	CbGpPWpGaD
Dicyclomine—CHRM1—Signaling Pathways—PIK3R1—obesity	1.81e-05	4.63e-05	CbGpPWpGaD
Dicyclomine—CHRM1—Signaling Pathways—NOS3—obesity	1.81e-05	4.63e-05	CbGpPWpGaD
Dicyclomine—CHRM2—Signaling Pathways—RHOA—obesity	1.81e-05	4.62e-05	CbGpPWpGaD
Dicyclomine—CHRM3—Signaling Pathways—PIK3R1—obesity	1.8e-05	4.62e-05	CbGpPWpGaD
Dicyclomine—CHRM3—Signaling Pathways—NOS3—obesity	1.8e-05	4.62e-05	CbGpPWpGaD
Dicyclomine—CYP1A1—Metabolism—ALB—obesity	1.79e-05	4.58e-05	CbGpPWpGaD
Dicyclomine—CHRM2—Signaling Pathways—PIK3R1—obesity	1.79e-05	4.57e-05	CbGpPWpGaD
Dicyclomine—CHRM2—Signaling Pathways—NOS3—obesity	1.79e-05	4.57e-05	CbGpPWpGaD
Dicyclomine—CHRM1—Signaling by GPCR—PIK3CA—obesity	1.72e-05	4.41e-05	CbGpPWpGaD
Dicyclomine—CHRM3—Signaling by GPCR—PIK3CA—obesity	1.72e-05	4.4e-05	CbGpPWpGaD
Dicyclomine—CYP1A1—Metabolism—PIK3R1—obesity	1.71e-05	4.39e-05	CbGpPWpGaD
Dicyclomine—CYP1A1—Metabolism—NOS3—obesity	1.71e-05	4.39e-05	CbGpPWpGaD
Dicyclomine—CHRM2—Signaling by GPCR—PIK3CA—obesity	1.7e-05	4.35e-05	CbGpPWpGaD
Dicyclomine—CHRM1—Signaling Pathways—MTOR—obesity	1.67e-05	4.27e-05	CbGpPWpGaD
Dicyclomine—CHRM1—Signaling Pathways—PIK3CB—obesity	1.67e-05	4.27e-05	CbGpPWpGaD
Dicyclomine—CHRM3—Signaling Pathways—PIK3CB—obesity	1.67e-05	4.26e-05	CbGpPWpGaD
Dicyclomine—CHRM3—Signaling Pathways—MTOR—obesity	1.67e-05	4.26e-05	CbGpPWpGaD
Dicyclomine—CHRM2—Signaling Pathways—PIK3CB—obesity	1.65e-05	4.22e-05	CbGpPWpGaD
Dicyclomine—CHRM2—Signaling Pathways—MTOR—obesity	1.65e-05	4.22e-05	CbGpPWpGaD
Dicyclomine—CYP1A1—Metabolism—PIK3CB—obesity	1.58e-05	4.05e-05	CbGpPWpGaD
Dicyclomine—CYP1A1—Metabolism—PTGS2—obesity	1.57e-05	4.01e-05	CbGpPWpGaD
Dicyclomine—CHRM1—GPCR downstream signaling—AKT1—obesity	1.55e-05	3.97e-05	CbGpPWpGaD
Dicyclomine—CHRM3—GPCR downstream signaling—AKT1—obesity	1.55e-05	3.96e-05	CbGpPWpGaD
Dicyclomine—CHRM2—GPCR downstream signaling—AKT1—obesity	1.53e-05	3.92e-05	CbGpPWpGaD
Dicyclomine—CHRM1—Signaling by GPCR—IL6—obesity	1.53e-05	3.91e-05	CbGpPWpGaD
Dicyclomine—CHRM3—Signaling by GPCR—IL6—obesity	1.52e-05	3.89e-05	CbGpPWpGaD
Dicyclomine—CHRM2—Signaling by GPCR—IL6—obesity	1.51e-05	3.86e-05	CbGpPWpGaD
Dicyclomine—CHRM1—Signaling Pathways—MMP9—obesity	1.45e-05	3.72e-05	CbGpPWpGaD
Dicyclomine—CHRM3—Signaling Pathways—MMP9—obesity	1.45e-05	3.7e-05	CbGpPWpGaD
Dicyclomine—CHRM2—Signaling Pathways—MMP9—obesity	1.43e-05	3.67e-05	CbGpPWpGaD
Dicyclomine—CHRM1—Signaling Pathways—MAPK8—obesity	1.41e-05	3.61e-05	CbGpPWpGaD
Dicyclomine—CHRM1—Signaling by GPCR—AKT1—obesity	1.41e-05	3.6e-05	CbGpPWpGaD
Dicyclomine—CHRM3—Signaling Pathways—MAPK8—obesity	1.41e-05	3.6e-05	CbGpPWpGaD
Dicyclomine—CHRM3—Signaling by GPCR—AKT1—obesity	1.4e-05	3.59e-05	CbGpPWpGaD
Dicyclomine—CHRM2—Signaling Pathways—MAPK8—obesity	1.39e-05	3.57e-05	CbGpPWpGaD
Dicyclomine—CHRM2—Signaling by GPCR—AKT1—obesity	1.39e-05	3.56e-05	CbGpPWpGaD
Dicyclomine—CHRM1—Signaling Pathways—STAT3—obesity	1.29e-05	3.3e-05	CbGpPWpGaD
Dicyclomine—CHRM3—Signaling Pathways—STAT3—obesity	1.29e-05	3.29e-05	CbGpPWpGaD
Dicyclomine—CHRM2—Signaling Pathways—STAT3—obesity	1.27e-05	3.26e-05	CbGpPWpGaD
Dicyclomine—CHRM3—Metabolism—PIK3CA—obesity	1.21e-05	3.11e-05	CbGpPWpGaD
Dicyclomine—CHRM1—Signaling Pathways—MYC—obesity	1.2e-05	3.07e-05	CbGpPWpGaD
Dicyclomine—CHRM1—Signaling Pathways—TGFB1—obesity	1.2e-05	3.06e-05	CbGpPWpGaD
Dicyclomine—CHRM3—Signaling Pathways—MYC—obesity	1.2e-05	3.06e-05	CbGpPWpGaD
Dicyclomine—CHRM3—Signaling Pathways—TGFB1—obesity	1.19e-05	3.05e-05	CbGpPWpGaD
Dicyclomine—CHRM2—Signaling Pathways—MYC—obesity	1.18e-05	3.03e-05	CbGpPWpGaD
Dicyclomine—CHRM2—Signaling Pathways—TGFB1—obesity	1.18e-05	3.02e-05	CbGpPWpGaD
Dicyclomine—CHRM1—Signaling Pathways—PIK3CA—obesity	1.02e-05	2.61e-05	CbGpPWpGaD
Dicyclomine—CHRM3—Signaling Pathways—PIK3CA—obesity	1.02e-05	2.6e-05	CbGpPWpGaD
Dicyclomine—CHRM2—Signaling Pathways—PIK3CA—obesity	1.01e-05	2.57e-05	CbGpPWpGaD
Dicyclomine—CHRM3—Metabolism—AKT1—obesity	9.92e-06	2.54e-05	CbGpPWpGaD
Dicyclomine—CYP1A1—Metabolism—PIK3CA—obesity	9.65e-06	2.47e-05	CbGpPWpGaD
Dicyclomine—CHRM1—Signaling Pathways—IL6—obesity	9.02e-06	2.31e-05	CbGpPWpGaD
Dicyclomine—CHRM3—Signaling Pathways—IL6—obesity	8.99e-06	2.3e-05	CbGpPWpGaD
Dicyclomine—CHRM2—Signaling Pathways—IL6—obesity	8.9e-06	2.28e-05	CbGpPWpGaD
Dicyclomine—CHRM1—Signaling Pathways—AKT1—obesity	8.32e-06	2.13e-05	CbGpPWpGaD
Dicyclomine—CHRM3—Signaling Pathways—AKT1—obesity	8.29e-06	2.12e-05	CbGpPWpGaD
Dicyclomine—CHRM2—Signaling Pathways—AKT1—obesity	8.21e-06	2.1e-05	CbGpPWpGaD
Dicyclomine—CYP1A1—Metabolism—AKT1—obesity	7.88e-06	2.02e-05	CbGpPWpGaD
